The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer.

The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Chemotherapy, Adjuvant
Combined Modality Therapy
Cyclophosphamide
Doxorubicin
Female
Humans
Lung Neoplasms
Male
Methotrexate
Middle Aged
Neoplasm Staging
Procarbazine
Retrospective Studies
Survival Analysis

authors with profiles

Mark K. Ferguson
Harvey M. Golomb
Philip Charles Hoffman